Upgrade to SI Premium - Free Trial

Mallinckrodt (MNK) Announces Completion of Hemostasis Drug Portfolios Acquisition from Medicines Co. (MDCO)

February 1, 2016 8:51 AM
Mallinckrodt plc (NYSE: MNK) announced it closed the acquisition of the global portfolio of three commercial-stage topical hemostasis drugs from ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Corporate News FDA Mergers and Acquisitions Spinoffs

Next Articles